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This paper reports the first attempt to characterize the penicillin-binding 
proteins (PBPs) of Shigella dysenteriae, an important human pathogen. The 
PBP pattern of the membranes of 5. dysenteriae closely resembles that of 
Escherichia coli membranes. A 38 kDa PBP which is an important target for the 
penem SCH34343, the cephamycin cefoxitin and the oxacephem moxalactam, 
has been purified. This PBP is immunologically related to a PBP of similar 
molecular mass in E. coli and is present at high levels in stationary-phase cells 
of S. dysenteriae. 
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INTRODUCTION 
Penicillin-binding proteins (PBPs), so named because of 
their affinity for penicillins and other beta-lactam anti- 
biotics, are important membrane-bound enzymes in- 
volved in bacterial peptidoglycan synthesis (Ghuysen, 
1991). The PBSs fall into three broad classes: the class A 
high molecular mass (HMM) PBPs, which possess trans- 
peptidase and transglycosylase activities ; the class B 
HMM PBPs, which possess transpeptidase and possibly 
other activities; and the low molecular mass (LMM) PBPs 
(Ghuysen, 1991). The HMM PBPs appear to be important 
in cell elongation, septation or shape determination 
(Matsuhashi e t  al., 1990; Wientjes & Nanninga, 1991). 
The LlLiM PBPs usually catalyse acyl transfer reactions 
from u-alanyl-D-alanine terminated peptides and 
depsipeptide analogues (Ghuysen, 1991 ; Waxman & 
Strominger, 1979) to suitable acceptors. Biochemical and 
genetic studies have shown that resistance to beta-lactam 
antibiotics may involve alteration in the structural genes 
of several of the PBPs (Dowson e t  al., 1989; Laible e t  al., 
1989; Spratt, 1994) and formation of low-affinity PBPs 
(Hakenbeck e t  al., 1991; Piras e t  al., 1990; Reynolds & 
Fuller, 1986; Utsui & Yokota, 1985). 
The PBPs of Escbericbia coli were initially characterized by 
Abbreviations: PBP, penicillin-binding protein; HMM, high molecular 
mass; LMM, low molecular mass. 
binding of radioactive penicillin to the cell membranes. 
Subsequently, an enormous amount of knowledge has 
been generated on the physiological roles of several PBPs 
of E. coli (Ghuysen, 1991 ; Georgopapadakou, 1993), and 
their genes have been cloned and sequenced. In contrast, 
there has been no study on the related human pathogen 
Sbigella, which is one of the major causes of diarrhoea 
related to morbidity and mortality, especially among 
children (Bennish & Salam, 1992). This paper describes 
the first attempt to identify the PBPs of Sbigella ujsenteriae 
and is also the first report on the purification and 
characterization of one of the PBPs of S. ujsenteriae. 
METHODS 
Antibiotics and chemicals. Ben~yl[~~C]penicillin was purchased 
from Amersham; flucloxacillin, temocillin, ticarcillin and 
cloxacillin were gifts from SmithKline Beecham ; SCH 34343 
was a gift from the Schering Plough Corporation; all other 
antibiotics were purchased from Sigma. 
Growth of organism and determination of minimum in- 
hibitory concentrations (MICs) of different antibiotics. S. 
4senteriae type I strain PB-10 was obtained from the stock 
culture of the National Institute of Cholera and Enteric Diseases, 
WHO Collaborating Centre for Diarrhoea1 Diseases Research 
and Training, Calcutta, India. Growth was routinely carried out 
in Tryptic soybroth (Difco) at 37 "C. MICs of antibiotics were 
determined by growing S. &senteriae in serial dilutions of the 
antibiotics on Mueller-Hinton agar plates. 
Preparation of membranes. Harvested cells were washed with 
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0.01 M HEPES (pH 7.5) and disrupted by sonication (Labsonic 
2000, Braun) employing four 1 min pulses with an interval of 
1 min between the pulses. After removal of cell debris by 
centrifugation, membranes were pelleted by centrifugation at 
16 000 g for 30 min. This pellet was washed with 0.01 M HEPES 
(pH 7.5) and stored at -70 "C. 
PBP assays. Samples (100 pg) of membrane proteins were 
incubated at 30 "C for 10 min with different concentrations of 
ben~yl['~C]penicillin (0.5 mCi mol-l, 18.5 MBq mole'). The re- 
action was stopped by addition of an excess of non-radioactive 
penicillin and sodium lauroyl sarcosinate (final concentration, 
1 Oh, w/v). The samples were allowed to stand at room 
temperature for 60 min, centrifuged and SDS gel denaturing 
buffer was added to the supernatants and boiled immediately for 
3 min. Samples were applied to 10 % SDS-polyacrylamide gels. 
For the purified PBP, 0.5 pg protein was used in each assay. In 
competition experiments, membranes were first incubated with 
different concentrations of the competing antibiotic for 10 rnin 
at 30 OC and then with saturating concentrations of radioactive 
penicillin for 10 min at 30 "C (Pierre e t  al., 1990); the reaction 
was terminated in the usual manner, followed by SDS-PAGE, 
fluorography and densitometric scanning of the fluorograms. 
Solubilization of the membranes with Triton X-100. 
Membranes (1 g protein) were solubilized in 10 mM Tris/HCl 
(pH 8) containing 0.1 mM dithioerythritol and 1 O/O (v/v) 
Triton X-100 (buffer A) on ice for 60 min. The supernatant was 
collected after centrifugation at  100000 g for 90 min. This 
supernatant is referred to as the Triton X-100 extract. 
Purification of the 38 kDa PBP. The pH of the Triton X-100 
extract was adjusted to 5.8 with HC1 and the extract was loaded 
on a Q-Sepharose Fast Flow (Pharmacia) column (20 ml) 
equilibrated in 25 mM Bis-Tris, pH 5.8, containing 10 7'0 (v/v) 
glycerol and 0.5 mM dithioerythritol (buffer B). Bound proteiris 
were then eluted with a gradient of 0-1 M NaCl in buffer 13. 
Fractions containing penicillin-binding activity were checked 
for homogeneity by SDS-PAGE. Active fractions were 
neutralized with 0.1 M NaOH and stored at -20 "C. 
Monitoring the purification. This was done as described hy 
Basu e t  al. (1992). Protein samples (50 pl) were incubated with 
5 pl ben~yl['~C]penicillin (50 mCi mmol-', 1850 MBq mmol-l; 
final concentration 34 pg ml-l) for 10 min at 30 "C and thcn 
precipitated with 0.5 ml 5 % (w/v) trichloroacetic acid and 5 pl 
10 YO Triton X-100. Samples were kept on ice for 5 min, and the 
precipitate was collected on Whatman GF/C filter circles with a 
Millipore filtration apparatus. The filters were washed four 
times with 2 ml 5 %  trichloroacetic acid and then washed four 
times with 2 ml 47 % (v/v) ethanol containing 0.01 M HC1. 
Filters were dried and their radioactivity measured. 
Determination of enzyme activities. The DD-carboxypeptidase 
activity was estimated by measuring the hydrolysis of rhe 
tripeptide diacetyl-L-Lys-D-Ala-D-Ala (Frere e t  al., 197 6). 
Briefly, the substrate was incubated with purified PBP (4-10 pg) 
at 37 "C for 30 min. The D-Ala released was estimated by 
addition of a mixture of o-dianisidine, flavin adenine dinucleo- 
tide, peroxidase and D-amino acid oxidase, and incubation 
for 10 min at 37 OC, followed by addition of methanol/sulphuric 
acid/water (5 : 6 : 5, by vol.). Spectrophotometric readings u'ere 
recorded at 535 nm. Standard curves were prepared by using D- 
Ala alone. Membranes (75 pg) of E. coli and S. 4senteriae were 
also assayed as described by Waxman & Strominger (1979;. 
Raising of antibodies against the 38 kDa PBP. Purified 38 kDa 
PBP (75 pg) was injected subcutaneously with complete 
Freund's adjuvant into one male rabbit. Successive injections of 
40 pg each with incomplete Freund's adjuvant were repeated at 
the end of the 2nd, 3rd and 4th weeks, followed by bleeding at 
the end of the 5th week. 
Western blotting and immunoprecipitation. Membranes of S. 
4senteriae or E. coli I<12 were run on 10 % SDS-polyacrylamide 
gels. Western blotting using anti-38 kDa PBP antibodies at a 
dilution of 1 : 250 was performed according to the method of 
Towbin e t  al. (1 979) with horseradish-peroxidase-linked anti- 
rabbit IgG as the second antibody and 4-chloro-1 -naphthol as 
the colour development reagent. Immunoprecipitation was 
performed on Triton X-100 extracts of membranes using anti- 
38 kDa antibody (1 : 250) and protein A-bearing Staph_ylococczts 
aureus cells as described by Firestone & Winguth (1990). Prior to 
electrophoresis, the complex was boiled for 5 min with SDS gel 
denaturing buffer. 
Preparation of spheroplasts. Cells were pelleted from ex- 
ponentially growing cultures and resuspended in 15 mM 
Tris/HCl buffer (pH 8) containing 12.5 YO (w/v) sucrose (buffer 
C) at a concentration of 2 x lolo cells ml-l as described by 
Broome-Smith & Spratt (1986). Cells were then treated with 
lysozyme (2 mg ml-l)/EDTA (5 mM) in buffer C for 25 rnin at 
37 "C. Under these conditions all the cells were converted to 
spheroplasts. 
Protease digestion of the 38 kDa PBP in spheroplasts. 
Spheroplasts were incubated at room temperature with pro- 
teinase K at final concentrations ranging from 0.1 to 2 mg ml-'. 
The digestion was stopped by 100 mM PMSF, then samples 
were denatured and fractionated on a 10 YO SDS-polyacrylamide 
gel. The proteins were electrophoretically transferred to a 
nitrocellulose sheet and probed with anti-38 kDa antibody as 
described by Towbin e t  al. (1979). 
N-terminal sequence analysis. Automated sequencing was 
performed on a 477A pulsed liquid sequenator with on-line 
analysis of the amino acid phenylthiohydantoin derivatives with 
a 120A analyser (Applied Biosystems). 
RESULTS 
MlCs of different beta-lactam antibiotics against S. 
dysenteriae 
The MICs of different beta-lactam antibiotics against S. 
hsenteriae are shown in Table 1. The organism was 
resistant to all the penicillins tested. Of the other beta- 
lactams tested, the most effective were ceftriaxone, the 
penem SCH34343 developed by Schering Plough Cor- 
poration (Das e t  al., 1988), the cephamycin cefoxitin and 
the oxacephem moxalactam. 
The organism was found to elaborate an intracellular 
constitutive beta-lactamase. The contribution of this beta- 
lactamase activity towards the antibiotic susceptibility/ 
resistance profile of the organism is the subject of a 
separate study. 
PBP pattern of the membranes of S. dysenteriae 
The membranes of S. hsenteriae PB-10 contained seven 
major PBPs, of molecular masses 84,68,63,52,46,39 and 
38 kDa (Fig. 1). A comparison with the PBPs of E. coli 
K12 is presented in Fig. 1. PBP 1 of S. 4senteriae could be 
Penicillin-binding protein from S. 4senteriae 
Tabre 1. Efficacy of different beta-lactam antibiotics against PBP 7 and other PBPs of 5. dysenteriae 
Anti biotic 1% (MI MIC 
(Pg m1-9 
P B P l  PBP2 PBP 3 PBP 4 PBP 5 PBP 6 PBP 7 
Ampicillin 8 x 8 x lop4 8 x lo-' 8 x > 8 x lop4 > 8 x lod4 > 8 x 
Flucloxacillin 8 x 8 x low4 > 8 x > 8 x 8 x 8 x 8 x 
Ticarcillin 8 x lop4 8 x 8 x 8 x lop4 > 8 x loT3 > 8 x lov3 8 x lop4 
Amoxycillin 8 x > 8 x 8 x 8 x lop4 > 8 x > 8 x 8 x 
Cefrriaxone 8 x 8 x 8 x > 8 x > 8 x 8 x lop4 8 x lop3 
Cefoxi tin 8 x lop5 8 x 8 x 8 x lop6 8 x 8 x 8 x 
Moxalactam 8 x lop4 > 8 x lop4 8 x 8 x lov4 8 x lop4 8 x lop5 8 x 
SCH34343 8 x < 8 x lop6 ND ND 8 x loF6 8 x < 8 x lop7 
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Fig. 1. PBP pattern of the isolated plasma membranes of E. coli 
(lane A) and 5. dysenteriae (lane B). The molecular masses (kDa) 
of the PBPs are as follows. E. coli: PBP l(a, b), 92; PBP 2, 68; PBP 
3, 65; PBP 4, 52; PBP 516, 45/42; and PBP 7, 38. 5. dysenteriae: 
PBP l(a, b), 84; PBP 2, 68; PBP 3, 63; PBP 4, 52; PBP 5,46; PBP 6, 
39; and PBP 7, 38. 
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Fig. 2. Purification of the 38 kDa PBP of 5. dysenteriae from a 
Q-Sepharose Fast Flow column as described in Methods. The 
arrow indicates the penicillin-binding activity corresponding to 
the 38 kDa PBP. -, A,,; @, [14C]penicillin bound. 
resolved into two bands, l a  and lb ,  under some con- 
ditions, as in the case of E. coli. PBPs 2, 3 and 4 of S. 
4senteriae appeared to have molecular masses similar to 
PBPs 2 , 3  and 4 of E. coli. PBPs 5 and 6 of E. coli could be 
seen as two distinct bands when shorter exposure times of 
the gels to the X-ray films were used. However, PBP 5 of 
S. 4senteriae could not be resolved into more than one 
band. S. 4senteriae showed two additional LMM PBPs of 
39 and 38 kDa. PBPs with molecular masses of about 
30-34 kDa have been reported in E. coli (Barbas e t  al., 
1986). The 38 kDa PBP observed by us in E. coli probably 
corresponds to PBP 7 of E. coli reported by earlier 
workers. It may be mentioned that the molecular masses 
of the E. coli PBPs determined by us differed slightly from 
those reported by Spratt (1977), namely 91 kDa (l), 
66 kDa (2), 60 kDa (3), 49 kDa (4), 42 kDa (5) and 40 kDa 
(6). Such differences have been observed by other workers 
also. All the PBPs were saturated at concentrations of 
benzylpenicillin > M (data not shown), indicating 
that all the PBPs are fairly resistant towards penicillin, and 
suggesting that this is one of the factors contributing 
towards the resistance of the organism towards penicillins. 
Purification of a 38 kDa PBP 
The Triton X-100 extract was adjusted to pH 5.8 with 
HC1, loaded on a Q-Sepharose column equilibrated in 
25 mM Bis-Tris, pH 5.8, containing 10% glycerol and 
eluted as described in Methods. One of the PBPs eluted 
from the column at an NaCl concentration close to 1 M 
(Fig. 2). Its homogeneity was confirmed by [14C]penicillin 
binding followed by SDS-PAGE and fluorography (Fig. 
3). This PBP had a molecular mass of 38 kDa, and 
corresponds to PBP 7 of S. hsenteriae. A total of 200 pg of 
purified PBP 7 was obtained from 1 g of membrane 
protein. 
N-terminal sequence analysis 
N-terminal sequence analysis (Fig. 4) showed that the 
38 kDa PBP does not have sequence homology with any 
of the E. coli PBPs cloned and sequenced so far. It also 
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Fig. 3. SDS-PAGE of the purified 38 kDa PBP of 5. dysenteriae. 
Lane A, Coomassie blue-stained ?el; lane B, fluorogram 
obtained after binding of benzyl[l Clpenicillin at  saturating 
concentration. 
20 25 30 
L - L - K - T - A - E - H - L - L - G - N - Q - ' - N - V  
Fig, 4. N-terminal sequence of the purified 38 kDa PBP of 5. 
dysenteriae. 
further confirmed the homogeneity of the purified pro- 
tein. 
Determination of DD-carboxypeptidase activity of the 
purified PBP 
DD-Carboxypeptidase activity of the purified PBP was 
determined in a model reaction using diacetyl-L-Lys-D- 
Ala-D-Ala as substrate. Under the conditions of our assay, 
no DD-carboxypeptidase activity could be demonstrated. 
However, DD-carboxypeptidase activity was detected in 
positive controls of membranes of both E. coli and S. 
ajmnteriae. 
Competition experiments 
The relative efficacy of different beta-lactams in binding to 
the purified 38 kDa PBP was determined by studying 
their ability to inhibit ben~yl[~~C]penicillin bi ding as 
described in Methods. The 90% inhibitory doses (IDgo) 
for the different antibiotics are given in Table 1. The 
resistance of the PBPs towards the penicillins in general 
suggests that this is one of the factors contributing 
towards the resistance of the organism against penicillins. 
The 38 kDa PBP (PBP 7) was sensitive to cefoxitin, SCH 
34343 and moxalactam. Although PBP 7 is not the 
exclusive target of any of these antibiotics, it may be one 
of the important targets for each of these antibiotics. 
Further studies are needed in order to draw conclusions. 
Fig. 5. Identification of a 38 kDa PBP in E. coli which is 
immunochemically related to the 38 kDa PBP of 5. dysenteriae. 
Lane A, bands visualized in 5. dysenteriae membranes after 
[14C]penicillin binding and fluorography; lane B, Western blot 
of purified 38 kDa PBP with anti-38 kDa antibody; lane C, 
Western blot of 5. dysenteriae membranes with anti-38 kDa 
antibody; lanes D and E, bands visualized after [14C]penicillin- 
binding followed by Triton X-100 extraction, immuno- 
precipitation and fluorography of membrane proteins of 5. 
dysenteriae and E. coli, respectively. 
Detection of 38 kDa protein(s) in E. coli membranes 
using anti-38 kDa antibody 
The anti-38 kDa antibody of S. ujsenteriae was cross- 
reactive with a single protein from S. hsetzteriae 
membranes (Fig. 5) as well as from E. coli membranes 
(data not shown). Since Western blots may give positive 
bands with comigrating species other than PBP(s) when 
membranes are used, immunoprecipitation was per- 
formed after radioactive penicillin binding. Briefly, 
membranes of E.  coli and S. ujsenteriae were solubilized 
with Triton X-100 (as described before) after labelling 
with radioactive penicillin. The Triton X-100 extracts 
were incubated successively with anti-38 kDa antibody 
and Protein A-containing S. aztrezts cells followed by 
centrifugation, in order to immunoprecipitate cross- 
reactive proteins. The pellet was boiled with SDS gel 
denaturing buffer, followed by SDS-PAGE and fluoro- 
graphy. As evident from Fig. 5, lanes D and E, the 
immunoprecipitated proteins from E. coli and S. ujsenteriae 
were both PBPs of Mr 38000, corresponding to PBP 7 of 
S. ujsenteriae. 
Protease digestion of the 38 kDa PBP in spheroplasts 
This was done essentially as described by Bowler & Spratt 
(1989) to establish the membrane topology of PBP 3 of E. 
coli. Western blotting revealed that the 38 kDa PBP is 
susceptible to proteolysis from the periplasmic side, since 
incubation of spheroplasts with proteinase K led to a 
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Fig. 6. Protease digestion of the 38 kDa PBP in spheroplasts. 
Spheroplasts prepared from 5. dysenteriae were incubated with 
proteinase K as described in Methods a t  concentrations of: 0 
(lane B), 16 (lane C), 80 (lane D), 400 (lane E) and 2000 (lane F) 
pg m1-l. Lane A, pure 38 kDa PBP. Samples were fractionated by 
SDS-PAGE, transferred to nitrocellulose membranes and probed 
with anti-38 kDa PBP antibody. The arrow indicates the position 
of the 38 kDa PBP. Relative mobilities of molecular mass 
markers are indicated. 
(a) 
A B C D E F 
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Fig. 7. Penicillin-binding activity (a) and levels (b) of the 38 kDa 
PBP a t  different sta es of growth. (a) Penicillin-binding activity 
dysenteriae a t  different stages of growth. Lanes A, B, C, D, E, F 
and G represent 0.5, 1, 2, 3, 4, 6 and 10 h of growth, 
respectively. (b) Levels of the 38 kDa PBP at different stages of 
growth were assessed in membranes using the anti-38 kDa 
antibody. Lanes A, B, C, D, E, F and G represent 1, 2, 4, 6, 8, 10 
and 12 h of growth, i.e. cell densities of 1.2, 3.2, 18.3, 23.5, 23.5 
and 23-5 ( x  10’) cells ml-’, respectively. 
was studied by [’ % Clpenicillin-binding to membranes of 5. 
complete digestion of the 38 kDa PBP (Fig. 6). Bowler & 
Spratt (1989) demonstrated that proteinase K at a 
concentration as high as 2000 pg ml-’ does not destroy 
the integrity of the spheroplasts. 
Expression of the 38 kDa PBP at different stages of 
growth 
The level of the 38 kDa PBP at different stages of growth 
was monitored by studying penicillin-binding activity in 
membranes at different stages of growth, as well as by 
Western blotting using the anti-38 kDa antibody. Both 
these methods showed that the level of this PBP gradually 
increased, reaching a maximum at 6 h of growth, i.e. 
when the cells had reached stationary phase. The level 
thereafter remained steady (Fig. 7). The gradual increase 
in intensity of the band obtained after penicillin-binding 
and fluorography, reaching its maximum at the stationary 
phase, was unique to this PBP (Fig. 7a). 
DISCUSSION 
Penicillin-binding proteins have been extensively studied 
in E. coli. However, the present study is the first attempt 
to characterize the PBPs of S. ujsenteriae. The pattern of 
the PBPs of S. ujsenteriae, not surprisingly, resembles that 
of E. coli. The general resistance of the PBPs of S. 
4senteriae towards benzylpenicillin suggests that this may 
be one of the causes of the resistance of the organism 
towards penicillins, although the contribution of other 
factors, such as the beta-lactamase, and outer membrane 
permeability, cannot be overlooked. The 38 kDa PBP 
purified by us is the first PBP to have been purified from 
S. ujselzteriae. This PBP corresponds to PBP 7 in our 
present nomenclature of the PBPs of this organism. Since 
antibody raised against this PBP gives only one positive 
38 kDa band in Western blots of membranes, the possi- 
bility that this PBP may be a degradation product of some 
other PBP may be ruled out. This PBP is cross-reactive 
with a 38 kDa PBP of E. coli which is of lower molecular 
mass than PBP 6 of E. coli. Its N-terminal sequence does 
not bear homology with that of any PBP from E. coli. The 
purification of this PBP therefore opens up the possibility 
of detailed studies on a hitherto uncharacterized beta- 
lactam target in enterobacteria. The sensitivity of this PBP 
towards SCH 34343, cefoxitin and moxalactam suggests 
that this PBP is one of the targets of these antibiotics, to 
which the organism itself is susceptible. However, it does 
not indicate that the 38 kDa PBP is the only target. The 
increased level of this PBP in particular in stationary- 
phase cells deserves further investigation into the possible 
role of this PBP in the stationary phase. PBP 6 of E. culi 
has been reported to be increased in stationary-phase cells 
(Buchanan & Sowell, 1982) and its possible role in 
stabilization of stationary-phase peptidoglycan has been 
suggested (Van der Linden e t  al., 1992). The failure to 
demonstrate DD-carboxypeptidase activity associated with 
the 38 kDa PBP does not conclusively prove the absence 
of this activity, since its loss during the course of 
purification cannot be ruled out. However, no carboxy- 
peptidase activity has been demonstrated even in the 
case of PBP 7 of E. coli. PBP 7 of E. coli has been identified 
as an important target for beta-lactams in non-growing 
cells (Tuomanen & Schwartz, 1987). The present study 
further strengthens the possibility that the LMM PBPs 
may be physiologically significant beta-lactam targets. 
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